Moshe Alafi, Ten Percent Owner at Intra-Cellular Therapies, holds 3.60M shares in Intra-Cellular Therapies (Ticker: ITCI), holds 2.33M shares in Stereotaxis (Ticker: STXS). Most recently, Moshe Alafi Bought ― shares of Intra-Cellular Therapies on Oct 03, 2017 for an estimated value of 4.00M.